Additionally, the silencing of GPx2 has been shown to reduce the expression of metalloproteinases (MMPs) MMP2 and MMP9 by downregulation of the Wnt pathway and inhibition of inflammation-mediated carcinogenesis, which are critical for cancer cell proliferation, migration, and invasion [54]. This evidence concerns the gene GPX2 and cancer.